HOME >> MEDICINE >> NEWS
Waterborne infectious diseases could soon be consigned to history, says expert

Waterborne infectious diseases, which bring death and illness to millions of people around the world, could largely be consigned to history by 2015 if global health partnerships integrate their programmes, according to Alan Fenwick writing in today's Science.

Professor Fenwick, from Imperial College London, argues that up to seven neglected tropical diseases including river blindness could be brought under control, with infection by some eliminated entirely, if existing programmes increase their coverage.

In Africa some 500 million people need treatment to control diseases such as disfiguring elephantiasis (lymphatic filariasis), river blindness (onchocerciasis), schistosomiasis, intestinal worms and the blinding eye infection trachoma.

The donation of drugs by pharmaceutical companies, together with financial donations from foundations, is already having a sizeable impact, with numbers given treatment for these diseases increasing from virtually zero in 1986 to between 20 and 80 million individuals annually in 2006.

More funding is required to convince decision makers of the benefits of treatment, to improve health education material and to deliver the drugs to those who need them. The cost can be as low as 25 pence per person per year, and the impact would be rapid.

"The current situation in Africa is such that most people living close to major rivers and lakes need not be subjected to the waterborne diseases that previously plagued them," writes Professor Fenwick.

"The programmes to prevent death, blindness and disfigurement have proved that they can work, and by 2006 they are reaching ever more people with donated or inexpensive drugs. The health of children in areas that have been reached is improving, and they are gaining a better start in life," he says.

Professor Fenwick leads the Schistosomiasis Control Initiative, which is supported by a 20 million donation from the Bill and Melin
'"/>

Contact: Laura Gallagher
L.Gallagher@imperial.ac.uk
44-020-759-46702
Imperial College London
24-Aug-2006


Page: 1 2

Related medicine news :

1. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
2. Travel ban could reduce spread of SARS or other infectious diseases
3. Use of antibiotic to treat infectious eye disease trachoma may increase risk for reinfection
4. Feds infectious diseases strategy must be broader than biodefense, say ID physicians
5. Presidents budget proposal cuts critical infectious diseases programs to the bone
6. New infectious agents pose new risks for people with bleeding disorders, Jefferson hematologist says
7. Marian Koshland Science Museum receives NIH funding for infectious diseases exhibit
8. Mathematics used to discern immune response to infectious diseases
9. Hospitalization rates for infectious diseases increase among older adults
10. Problem of emerging infectious diseases likely to worsen
11. Corticosteroids often used in treatment of infectious mononucleosis

Post Your Comments:
(Date:4/26/2015)... New York, New York (PRWEB) April 26, 2015 ... convened on April 21, 2015 in the U.S. ... of federally-filed testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) ... pretrial proceedings. According to court documents, matters addressed ... to seek dismissal of claims involving their products ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Italian public ... deadly legacy of asbestos cement plants and other asbestos-related ... the new research. Click here to read it ... Italy’s Department of Occupational and Environmental Medicine analyzed more ... and found 32 clusters where the asbestos cancer was ...
(Date:4/26/2015)... 26, 2015 Compare-autoinsurance.org has released a new ... quotes . , The easiest way to find low cost ... access to the best offers online, in a simple and ... providers for information about auto insurance prices. All the details ... page. , It is now possible to compare online ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Indiana Fiber ... provider announces that Brotherhood Mutual Insurance Company has selected ... Manager of Network Infrastructure at Brotherhood Mutual Insurance Company ... the service reliability Brotherhood Mutual needed. We ... and IFN worked with us to ensure we achieved ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from ... can quickly and easily add desaturated color grades to footage. ... formula for modifying an image. The LUT changes every pixel's ... pack comes with 60 black and white CUBE LUT files. ... and white films. With the FCPX LUT B&W Loader ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ... Drug Administration (FDA) has accepted its New Drug Application ... interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir ... treatment of adults with chronic genotype 4 (GT4) hepatitis ... the first all-oral, interferon-free therapy being evaluated by the ...
(Date:4/23/2015)...  ResMed Inc. (NYSE: RMD ) today announced ... for the quarter was $422.5 million, a 6 percent ... (a 13 percent increase on a constant currency basis).  ... percent compared to the quarter ended March 31, 2014.  ... an increase of 2 percent compared to the quarter ...
(Date:4/23/2015)... 2015 /CNW/ - Health Canada is working with the ... the safety information regarding the risk of serious cardiovascular ... products are used at high doses (at or above ... of use. Ibuprofen is a non-steroidal anti-inflammatory ... to reduce inflammation. The majority of ibuprofen products in ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4
Cached News: